Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Comprehensive definition of human immunodominant CD8 antigens in tuberculosis.

Lewinsohn DA, Swarbrick GM, Park B, Cansler ME, Null MD, Toren KG, Baseke J, Zalwango S, Mayanja-Kizza H, Malone LL, Nyendak M, Wu G, Guinn K, McWeeney S, Mori T, Chervenak KA, Sherman DR, Boom WH, Lewinsohn DM.

NPJ Vaccines. 2017;2. pii: 8. doi: 10.1038/s41541-017-0008-6. Epub 2017 Apr 3.


Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture.

Harausz EP, Chervenak KA, Good CE, Jacobs MR, Wallis RS, Sanchez-Felix M, Boom WH; TB Research Unit (TBRU) at Case Western Reserve University.

Tuberculosis (Edinb). 2016 May;98:92-6. doi: 10.1016/ Epub 2016 Mar 22.


Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.

Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit.

PLoS One. 2014 May 5;9(5):e96613. doi: 10.1371/journal.pone.0096613. eCollection 2014.


Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda.

Mahan CS, Zalwango S, Thiel BA, Malone LL, Chervenak KA, Baseke J, Dobbs D, Stein CM, Mayanja H, Joloba M, Whalen CC, Boom WH.

Am J Trop Med Hyg. 2012 Apr;86(4):690-7. doi: 10.4269/ajtmh.2012.11-0553.


Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH.

J Infect Dis. 2011 Apr 1;203(7):992-1001. doi: 10.1093/infdis/jiq141.


Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH; Uganda-Case Western Research Collaboration.

PLoS One. 2010 Feb 22;5(2):e9138. doi: 10.1371/journal.pone.0009138.


Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay.

Rojas RE, Chervenak KA, Thomas J, Morrow J, Nshuti L, Zalwango S, Mugerwa RD, Thiel BA, Whalen CC, Boom WH.

J Infect Dis. 2005 Nov 15;192(10):1806-14. Epub 2005 Oct 12.


Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.

Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH.

J Immunol. 1999 Jan 1;162(1):372-9.


Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis.

Havlir DV, Ellner JJ, Chervenak KA, Boom WH.

J Clin Invest. 1991 Feb;87(2):729-33.

Supplemental Content

Loading ...
Support Center